Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Cetuximab is an epidermal growth factor receptor (EGFR) inhibitor used for the treatment of metastatic colorectal cancer, metastatic non-small cell lung cancer and head and neck cancer.
The report details the trend, potential and market size of Cetuximab market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Cetuximabmarket, defines the market attractiveness level of Cetuximab market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Cetuximab industry, describes the types of Cetuximab market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cetuximab market and the development prospects and opportunities of Cetuximab industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cetuximab market in Chapter 13.
By Player:
Merck
Eli Lilly
By Type:
100 mg/50 mL Injection
200 mg/100 mL Injection
By End-User:
Head and Neck Cancer
Metastatic Colorectal Cancer
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Cetuximab Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Cetuximab Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Cetuximab Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Cetuximab Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Cetuximab Market Analysis and Outlook to 2022
-
7.1 Global Cetuximab Consumption (2017-2022)
-
7.2 United States Cetuximab Consumption (2017-2022)
-
7.3 Europe Cetuximab Consumption (2017-2022)
-
7.4 China Cetuximab Consumption (2017-2022)
-
7.5 Japan Cetuximab Consumption (2017-2022)
-
7.6 India Cetuximab Consumption (2017-2022)
-
7.7 South Korea Cetuximab Consumption (2017-2022)
8 Region and Country-wise Cetuximab Market Analysis and Outlook to 2028
-
8.1 Global Cetuximab Consumption Forecast (2022-2028)
-
8.2 United States Cetuximab Consumption Forecast (2022-2028)
-
8.3 Europe Cetuximab Consumption Forecast (2022-2028)
-
8.4 China Cetuximab Consumption Forecast (2022-2028)
-
8.5 Japan Cetuximab Consumption Forecast (2022-2028)
-
8.6 India Cetuximab Consumption Forecast (2022-2028)
-
8.7 South Korea Cetuximab Consumption Forecast (2022-2028)
9 Global Cetuximab Market Outlook by Types and Applications to 2022
-
9.1 Global Cetuximab Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 100 mg/50 mL Injection Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 200 mg/100 mL Injection Consumption and Growth Rate (2017-2022)
-
9.2 Global Cetuximab Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Head and Neck Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Metastatic Colorectal Cancer Consumption and Growth Rate (2017-2022)
10 Global Cetuximab Market Outlook by Types and Applications to 2028
-
10.1 Global Cetuximab Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 100 mg/50 mL Injection Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 200 mg/100 mL Injection Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Cetuximab Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Head and Neck Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Metastatic Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
11 Global Cetuximab Import and Export Analysis (Top 5 Countries)
-
11.1 Global Cetuximab Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Cetuximab Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Cetuximab Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Cetuximab Market Competitive Analysis
-
14.1 Merck
-
14.1.1 Merck Company Details
-
14.1.2 Merck Cetuximab Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Merck Cetuximab Product and Service
-
14.2 Eli Lilly
-
14.2.1 Eli Lilly Company Details
-
14.2.2 Eli Lilly Cetuximab Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Eli Lilly Cetuximab Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Cetuximab
-
Figure Cetuximab Picture
-
Table Global Cetuximab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cetuximab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cetuximab Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Cetuximab Consumption by Country (2017-2022)
-
Figure United States Cetuximab Consumption and Growth Rate (2017-2022)
-
Table Europe Cetuximab Consumption and Growth Rate (2017-2022)
-
Figure China Cetuximab Consumption and Growth Rate (2017-2022)
-
Figure Japan Cetuximab Consumption and Growth Rate (2017-2022)
-
Figure India Cetuximab Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cetuximab Consumption and Growth Rate (2017-2022)
-
Figure Global Cetuximab Consumption Forecast by Country (2022-2028)
-
Figure United States Cetuximab Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cetuximab Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Cetuximab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cetuximab Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cetuximab Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cetuximab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 100 mg/50 mL Injection Consumption and Growth Rate (2017-2022)
-
Figure Global 200 mg/100 mL Injection Consumption and Growth Rate (2017-2022)
-
Figure Global Head and Neck Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Metastatic Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global 100 mg/50 mL Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 200 mg/100 mL Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Head and Neck Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Metastatic Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Cetuximab Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Cetuximab Export by Region (Top 5 Countries) (2017-2028)
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Cetuximab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Cetuximab Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Cetuximab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Cetuximab Product and Service
-
